No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Radcliffe Group Appoints Dr. Peter O’Kane New Editor-in-Chief of Interventional Cardiology Review and Opens Journal to Original Research Through Its Title Change (ICR3)

Editor: What To Know

  • I will bring my cardiology experience to build on the strong foundations of the journal and develop strategies to promote original research submission whilst maintaining the recognized high quality of reviews and clinical resources that have been synonymous with Radcliffe Group and have undoubtedly guided patient care across the world”, said Dr.
  • He is committed to teaching and has trained many physicians both in the UK and internationally in devices such as rotational and laser atherectomy and developing technical skills such as those involved in bifurcation stenting and coronary imaging utilization.
  • He has contributed to 30 global research studies as a local principal investigator with a high provision of randomized patients and has co-authored more than 50 manuscripts in addition to 10 book chapters.

Radcliffe Group, a STM publisher and digital media producer of cardiovascular, renal, and metabolic content has announced Dr. Peter O’Kane as the new editor-in-chief of their journal, Interventional Cardiology: Reviews, Research, and Resources.

Dr. O’Kane was appointed as a consultant interventional cardiologist at the Royal Bournemouth Hospital in July 2007 and has performed more than 7,000 PCI cases. He has extensive experience with coronary physiology and intra-coronary imaging to guide intervention and the many tools and techniques to manage bifurcations, calcification, and chronic occlusions.

He is committed to teaching and has trained many physicians both in the UK and internationally in devices such as rotational and laser atherectomy and developing technical skills such as those involved in bifurcation stenting and coronary imaging utilization. He has presented at many cardiology conferences and performed as a live case operator. He has contributed to 30 global research studies as a local principal investigator with a high provision of randomized patients and has co-authored more than 50 manuscripts in addition to 10 book chapters.

With such a keen interest in clinical and academic cardiology, Dr. O’Kane is very excited to take this position. “It is a great privilege to accept the position of EiC for ICR3 and work alongside a fantastic team of clinicians, academics, and editors in this well-established publishing house. I will bring my cardiology experience to build on the strong foundations of the journal and develop strategies to promote original research submission whilst maintaining the recognized high quality of reviews and clinical resources that have been synonymous with Radcliffe Group and have undoubtedly guided patient care across the world”, said Dr. O’Kane.

Radcliffe Cardiology would like to thank Dr. Simon Kennon for his editorship of ICR over the last seven years and wish him well. He will continue to remain involved with the ICR journal as an editorial board member, supporting the incumbent Editor-in-Chief.

At the same time, ICR is changing its title to Interventional Cardiology: Reviews, Research, Resources (ICR3) and has now opened to receive submissions of original research. This is the next step in the journal’s development, and we are thrilled about the exciting opportunities to come.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy